Soleno Therapeutics, Inc. Stock
Stocks
SLNO
US8342033094
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-05-15 EDT
|
5-day change | 1st Jan Change | ||
| 53.01 USD | +0.04% |
|
-.--% | +14.49% |
| 09-08 | Kura Oncology Names Jennifer Fulk Finance Chief | MT |
| 06-15 | Soleno Therapeutics Announces Late-Breaking Data At Endo 2026 | CI |
| Market Cap | 2.76B 2.43B 2.3B 2.08B 3.91B 265B 3.94B 27.51B 10.63B 135B 10.37B 10.15B 435B | P/E 2024 |
-10.3x | P/E 2025 | 119x |
|---|---|---|---|---|---|
| Enterprise Value | 2.31B 2.03B 1.92B 1.74B 3.27B 222B 3.29B 23B 8.88B 113B 8.67B 8.48B 363B | EV / Sales 2024 |
-
| EV / Sales 2025 | 10,678,497x |
| Free-Float |
98.88% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Soleno Therapeutics, Inc.
| 1 day | +0.04% | ||
| 6 months | +76.41% | ||
| Current year | +14.49% |
| Current year | 29.43 |  | 53.01 |
| 1 year | 29.43 | | 72.88 |
| 3 years | 21.3 | | 90.32 |
| 5 years | 0.85 | | 90.32 |
| 10 years | 0.85 | | 99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darin Lippoldt
PSD | President | 61 | 2026-05-14 |
| Treasurer | 46 | 2026-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Darin Lippoldt
BRD | Director/Board Member | 61 | 2026-05-14 |
| Director/Board Member | 46 | 2026-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Issuer sale | Director | -16,991 | 0.0329% | ||
| 5/18/26 | Issuer sale | SEE REMARKS | -150,284 | 0.2911% | ||
| 5/18/26 | Issuer sale | Director | -19,554 | 0.0379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.04% | -.--% | -18.40% | +92.13% | 2.76B | |
| -0.37% | -3.67% | +57.21% | +87.75% | 71.81B | |
| +1.59% | +0.30% | +40.38% | +86.28% | 60.06B | |
| +0.19% | +1.61% | +35.10% | +17.20% | 27.93B | |
| -0.14% | -2.75% | -14.13% | +356.79% | 25.7B | |
| +0.57% | +1.10% | +1.02% | -2.89% | 24.89B | |
| +0.39% | +1.40% | +26.15% | -7.85% | 20.92B | |
| -1.70% | +0.43% | +150.24% | +323.16% | 15.04B | |
| +0.36% | +2.01% | +49.51% | +160.70% | 14.46B | |
| +3.91% | -3.51% | -4.56% | +517.49% | 13.87B | |
| Average | +0.48% | -1.36% | +32.25% | +163.07% | 27.74B | |
| Weighted average by Cap. | +0.45% | -1.89% | +38.15% | +128.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 190.4 167.46 158.35 143.63 269.74 18.28K 271.31 1.9K 732.26 9.33K 714.86 699.38 29.97K |
| Net income | -176M -155M -146M -133M -249M -16.88B -251M -1.75B -676M -8.61B -660M -646M -27.68B | 20.89M 18.37M 17.37M 15.76M 29.59M 2.01B 29.77M 208M 80.34M 1.02B 78.43M 76.73M 3.29B |
| Net Debt | -266M -234M -221M -201M -377M -25.52B -379M -2.65B -1.02B -13.02B -998M -976M -41.84B | -454M -399M -377M -342M -643M -43.54B -646M -4.52B -1.74B -22.22B -1.7B -1.67B -71.39B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SLNO Stock
Select your edition
All financial news and data tailored to specific country editions
